Integra LifeSciences Holdings Corp. (IART)
14.23
+0.57
(+4.17%)
USD |
NASDAQ |
Dec 11, 11:50
Integra LifeSciences Holdings Cash from Investing (Quarterly): -15.59M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Masimo Corp. | 282.30M |
| LeMaitre Vascular, Inc. | -27.45M |
| Clearpoint Neuro, Inc. | -0.199M |
| Tandem Diabetes Care, Inc. | 20.54M |
| iRhythm Technologies, Inc. | -89.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 40.91M |
| Cash from Financing (Quarterly) | -10.24M |
| Free Cash Flow | -14.47M |
| Free Cash Flow Per Share (Quarterly) | 0.3355 |
| Free Cash Flow to Equity (Quarterly) | 33.66M |
| Free Cash Flow to Firm (Quarterly) | 47.41M |
| Free Cash Flow Yield | -1.32% |